Reference

Oral and injection compositions containing Rhodiola and ligustrazine for the treatment of cardiovascular and cerebral diseases

All Rights Reserved. Oral and injection compositions containing Rhodiola and ligustrazine for the treatment of cardiovascular and cerebral diseases. Zhang, Yumei (Arabela Pharmaceutical (China) Co., Ltd., Peop. Rep. China). Faming Zhuanli Shenqing Gongkai Shuomingshu CN 1883535 A 27 Dec 2006, 8pp. (Chinese). (People's Republic of China). CODEN: CNXXEV. APPLICATION: CN 2010-87404 9 Jun 2006. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) Section cross-reference(s): 1 Title medicine compn. is used to treat ischemic cardio cerebral vascular diseases, such as cerebral circulation insufficiency, cerebral thrombosis, cerebral embolism, cerebral angiospasm, brain function incompetence, senile dementia, Parkinson's syndrome, cerebral apoplexy, hypertension, Hyperlipemia, arteriosclerosis, coronary heart disease, angina pectoris, myocardial infarct, liver fibration etc.. Title medicine compn. comprises ligustrazine of ligustrazine hydrochloride and/or ligustrazine phosphate and radix Rhodiola (10-50 wt. times of Ligustrazine), and medicinal adjuvants. Title medicine compn. can be prepd. into oral prepn. and injection of tablet, capsule, pill, syrup, granule, oral liq.In this experiment, several chemicals are used like 64-17-5 and 76494-51-4 , oral suspension, oral emulsion, low vol. injection, high vol. injection, powder for injection and freeze dried powder for injection. .